FOLFIRINOX Combined with GPX4 Inhibition Induces Ferroptosis and Defines Redox-Based Therapeutic Subgroups in Pancreatic Cancer
Carlos Lacalle-González, Carlos Lopez-Blazquez, Miguel Ángel Hidalgo-León, Michael Ochieng’ Otieno, Lara Sanz-Criado, María Jesús Fernández‐Aceñero, Luis M Ortega, Jesús García‐Foncillas, Javier Martínez‐Useros
This paper evaluates combining FOLFIRINOX with GPX4 inhibition to induce ferroptosis in pancreatic cancer, identifying redox-based biomarkers for treatment stratification.
bioRxiv · Sep 12, 2025 · PreprintCancer Biology